Improving HCV diagnosis following a false-negative anti-HCV result

Articles in the same Issue

1. Frontmatter
2. Editorial
3. Six years of progress – highlights from the IFCC Emerging Technologies Division
4. IFCC Papers
5. Skin in the game: a review of single-cell and spatial transcriptomics in dermatological research
6. Bilirubin measurements in neonates: uniform neonatal treatment can only be achieved by improved standardization
7. Validation and verification framework and data integration of biosensors and in vitro diagnostic devices: a position statement of the IFCC Committee on Mobile Health and Bioengineering in Laboratory Medicine (C-MBHLM) and the IFCC Scientific Division
8. Linearity assessment: deviation from linearity and residual of linear regression approaches
9. HTA model for laboratory medicine technologies: overview of approaches adopted in some international agencies
10. Considerations for applying emerging technologies in paediatric laboratory medicine
11. A global perspective on the status of clinical metabolomics in laboratory medicine – a survey by the IFCC metabolomics working group
12. The LEAP checklist for laboratory evaluation and analytical performance characteristics reporting of clinical measurement procedures
13. General Clinical Chemistry and Laboratory Medicine
14. Assessing post-analytical phase harmonization in European laboratories: a survey promoted by the EFLM Working Group on Harmonization
15. Potential medical impact of unrecognized in vitro hypokalemia due to hemolysis: a case series
16. Quantification of circulating alpha-1-antitrypsin polymers associated with different SERPINA1 genotypes
17. Targeted ultra performance liquid chromatography tandem mass spectrometry procedures for the diagnosis of inborn errors of metabolism: validation through ERNDIM external quality assessment schemes
18. Improving protocols for α-synuclein seed amplification assays: analysis of preanalytical and analytical variables and identification of candidate parameters for seed quantification
19. Evaluation of analytical performance of AQUIOS CL flow cytometer and method comparison with bead-based flow cytometry methods
20. IgG and kappa free light chain CSF/serum indices: evaluating intrathecal immunoglobulin production in HIV infection in comparison with multiple sclerosis
21. Reference Values and Biological Variations
22. Reference intervals of circulating secretoneurin concentrations determined in a large cohort of community dwellers: the HUNT study
23. Sharing reference intervals and monitoring patients across laboratories – findings from a likely commutable external quality assurance program
24. Verification of bile acid determination method and establishing reference intervals for biochemical and haematological parameters in third-trimester pregnant women
25. Confounding factors of the expression of mTBI biomarkers, S100B, GFAP and UCH-L1 in an aging population
26. Cancer Diagnostics
27. Exploring evolutionary trajectories in ovarian cancer patients by longitudinal analysis of ctDNA
28. Diabetes
29. Evaluation of effects from hemoglobin variants on HbA_1c measurements by different methods
30. Letters to the Editor
31. Are there any reasons to use three levels of quality control materials instead of two and if so, what are the arguments?
32. Issues for standardization of neonatal bilirubinemia: a case of delayed phototherapy initiation
33. The routine coagulation assays plasma stability – in the wake of the new European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) biological variability database
34. Improving HCV diagnosis following a false-negative anti-HCV result